This compound is a pharmaceutical intermediate featuring a complex oxolane ring substituted with trifluoromethyl, difluoromethoxyphenyl, and pyridinecarboxamide groups. It is primarily utilized as a building block in the synthesis of active pharmaceutical ingredients.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2649467-57-0
Suzetrigine Impurity 13
active pharmaceutical ingredient impurity
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid
pharmaceutical intermediate
N-Carbobenzoxy-L-glutamine
protected amino acid intermediate
(2S)-1-methoxypropan-2-ol
Pharmaceutical intermediate for olmesartan medoxomil
3-amino-N-(4-aminophenyl)benzamide
pharmaceutical intermediate
Suzetrigine
sodium channel blocker
4-[[(2S,3R,4R,5S)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)oxolane-2-carbonyl]amino]pyridine-2-carboxamide
XSQUJFKRXZMOKA-BHFKVQLUSA-N
C[C@@H]1[C@@H]([C@H](O[C@]1(C)C(F)(F)F)C(=O)NC2=CC(=NC=C2)C(=O)N)C3=C(C(=C(C=C3)F)F)OC